Healthcare provider profile · identity verified

Neyliz Ferrin, APRN

Nurse Practitioner · MIAMI, FL · NPI 1316559016

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	492	266
Vitamin D2	Ergocalciferol (Vitamin D2)	344	199
Gabapentin	Gabapentin	325	156
Levothyroxine Sodium	Levothyroxine Sodium	228	116
Rosuvastatin Calcium	Rosuvastatin Calcium	196	91
Simvastatin	Simvastatin	173	92
Losartan Potassium	Losartan Potassium	168	88
Omeprazole	Omeprazole	167	98
Folic Acid	Folic Acid	136	67
Famotidine	Famotidine	135	93
Lisinopril	Lisinopril	126	66
Amlodipine Besylate	Amlodipine Besylate	117	65
Xarelto	Rivaroxaban	117	50
Mupirocin	Mupirocin	112	78
Hydrocortisone	Hydrocortisone	107	56
Fluticasone Propionate	Fluticasone Propionate	104	61
Triamcinolone Acetonide	Triamcinolone Acetonide	93	64
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	91	70
Metoprolol Succinate	Metoprolol Succinate	87	37
Metformin Hcl	Metformin Hcl	81	41
Metoprolol Tartrate	Metoprolol Tartrate	72	35
Furosemide	Furosemide	70	48
Benzonatate	Benzonatate	69	55
Mirtazapine	Mirtazapine	69	37
Donepezil Hcl	Donepezil Hcl	63	36
Sildenafil Citrate	Sildenafil Citrate	60	26
Diclofenac Sodium	Diclofenac Sodium	58	47
Hydrochlorothiazide	Hydrochlorothiazide	54	31
Quetiapine Fumarate	Quetiapine Fumarate	54	25
Albuterol Sulfate Hfa	Albuterol Sulfate	53	31
Memantine Hcl	Memantine Hcl	53	20
Ketoconazole	Ketoconazole	52	34
Tamsulosin Hcl	Tamsulosin Hcl	52	32
Alendronate Sodium	Alendronate Sodium	49	30
Pantoprazole Sodium	Pantoprazole Sodium	47	35
Clopidogrel	Clopidogrel Bisulfate	46	23
Escitalopram Oxalate	Escitalopram Oxalate	46	20
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	13
Azelastine Hcl	Azelastine Hcl	45	34
Silver Sulfadiazine	Silver Sulfadiazine	45	26
Trazodone Hcl	Trazodone Hcl	45	28
Fenofibrate	Fenofibrate	44	18
Glipizide	Glipizide	42	23
Buspirone Hcl	Buspirone Hcl	40	31
Sertraline Hcl	Sertraline Hcl	37	22
Lactulose	Lactulose	35	24
Glipizide Er	Glipizide	31	12
Ondansetron Hcl	Ondansetron Hcl	31	27
Baclofen	Baclofen	30	25
Pravastatin Sodium	Pravastatin Sodium	30	19
Carvedilol	Carvedilol	29	17
Comfort Ez Pen Needle	Pen Needle, Diabetic	26	13
Nystatin	Nystatin	24	24
Atenolol	Atenolol	22	11
Ibuprofen	Ibuprofen	22	19
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Montelukast Sodium	Montelukast Sodium	21	16
Nyamyc	Nystatin	21	17
Synthroid	Levothyroxine Sodium	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	17
Allopurinol	Allopurinol	20	suppressed
Eliquis	Apixaban	20	12
Finasteride	Finasteride	20	13
Methenamine Hippurate	Methenamine Hippurate	20	suppressed
Ciclopirox	Ciclopirox Olamine	19	14
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Celecoxib	Celecoxib	17	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Mometasone Furoate	Mometasone Furoate	16	13
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Azithromycin	Azithromycin	15	15
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	12
Irbesartan	Irbesartan	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Meloxicam	Meloxicam	12	11
Nifedipine Er	Nifedipine	12	suppressed
Potassium Chloride	Potassium Chloride	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Levoxyl	Levothyroxine Sodium	11	suppressed
Naproxen	Naproxen	11	11
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error